This decommissioned ERA site remains active temporarily to support our final migration steps to https://ualberta.scholaris.ca, ERA's new home. All new collections and items, including Spring 2025 theses, are at that site. For assistance, please contact erahelp@ualberta.ca.
Search
Skip to Search Results
Filter
Subject / Keyword
- 1 Structure activity relationship analysis
- 1Cancer Therapy
- 1Cisplatin Ototoxicity
- 1Nitrofen
- 1TAK-242
- 1TLR4 antagonists
Author / Creator / Contributor
Year
Collections
Languages
Item type
Departments
Supervisors
-
Fall 2022
Cisplatin contributes to the approximately 80% five-year survival rate for childhood cancer patients. Despite its effectiveness, cisplatin causes several toxicities, particularly ototoxicity which manifests as permanent hearing loss. To date, limited success in otoprotection without compromised...
1 - 1 of 1